What is NDC 13668-014?

13668-014 is the product NDC for Levetiracetam, Levetiracetam 250 mg/1 tablet, listed with the FDA by Torrent Pharmaceuticals Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.

Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Levetiracetam?

268 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Levetiracetam NDC 13668-014 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-014Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0014Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
13668-014-05	1366800140513668001405	500 TABLET in 1 BOTTLE (13668-014-05)Marketed from Jan 15, 2009
13668-014-12	1366800141213668001412	120 TABLET in 1 BOTTLE (13668-014-12)Marketed from Jan 15, 2009
13668-014-25	1366800142513668001425	250 TABLET in 1 BOTTLE (13668-014-25)Marketed from Jan 15, 2009
13668-014-31	1366800143113668001431	2500 TABLET in 1 BOTTLE (13668-014-31)Marketed from Jan 15, 2009
13668-014-60	1366800146013668001460	60 TABLET in 1 BOTTLE (13668-014-60)Marketed from Jan 15, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levetiracetam
Generic name (nonproprietary): levetiracetam
Active ingredients: Levetiracetam — 250 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Torrent Pharmaceuticals LimitedNDC labeler code 13668
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078858
Marketing start: Jan 15, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 13668-014_b8792837-f86a-4e67-b1a5-ec8ca278fe77SPL ID b8792837-f86a-4e67-b1a5-ec8ca278fe77SPL set ID 6ab24168-058d-496e-9023-da8ee6353eb3RxCUI 311288, 311289, 311290, 387003UNII 44YRR34555UPC 0313668017601, 0313668016604, 0313668014600, 0313668015607

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668001405 followed by a unit qualifier and the quantity

Package 13668-0014-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2025.

Indications (excerpt from the label)

Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2 ) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3 ) 1.1 Partial-Onset Seizures Levetiracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam tablets are indicated as adjunctive therapy for the treatment o…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 13668-014

What is NDC 13668-014?: 13668-014 is the product NDC for Levetiracetam, Levetiracetam 250 mg/1 tablet, listed with the FDA by Torrent Pharmaceuticals Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Levetiracetam.
What is the active ingredient?: Levetiracetam.
Who is the labeler?: Torrent Pharmaceuticals Limited, NDC labeler code 13668. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Levetiracetam?: 268 other product NDCs are listed under this name. See all Levetiracetam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Levetiracetam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4792	70518-4792-00
Levetiracetam	Levetiracetam 250 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-696	72189-0696-30
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-0288	55154-0288-00
Levetiracetam	Levetiracetam 750 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-4731	70518-4731-00
Levetiracetam	Levetiracetam 100 mg/mL	Injection, Solution, ConcentrateIntravenous	Baxter Healthcare Corporation	36000-265	36000-0265-0536000-0265-10
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-046	87441-0046-01
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	Direct_Rx	72189-679	72189-0679-6072189-0679-82
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0420	67046-0420-03
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Injecta Medcial LLC	87234-0035	87234-0035-01
Levetiracetam	Levetiracetam 1000 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0863	67046-0863-03

All 269 Levetiracetam NDCs

Other NDCs under ANDA 078858

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078858
Product	Strength	Form · route	Labeler	Product NDC
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-015
Levetiracetam	Levetiracetam 750 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-016
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-017
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-499
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	OWP Pharmaceuticals, Inc.	69102-105
Levetiracetam	Levetiracetam 750 mg/1	TabletOral	OWP Pharmaceuticals, Inc.	69102-106
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	OWP Pharmaceuticals, Inc.	69102-107
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Bryant Ranch Prepack	71335-2282
Roweepralevetiracetam	Levetiracetam 250 mg/1	TabletOral	OWP Pharmaceuticals, Inc.	69102-108